Bagnasco et al., 1988 - Google Patents
Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroidBagnasco et al., 1988
- Document ID
- 7606398078528401007
- Author
- Bagnasco M
- Venuti D
- Prigione I
- Torre G
- Ferrini S
- Canonica G
- Publication year
- Publication venue
- Clinical immunology and immunopathology
External Links
Snippet
We have investigated at the clonal level the repertoire of intrathyroid and peripheral T lymphocytes in three patients with Graves' disease using a high efficiency cloning technique. Clonal efficiencies ranged from 10 to 31% for intrathyroid, and from 19 to 100% for …
- 210000001744 T-Lymphocytes 0 title abstract description 58
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MacKenzie et al. | Intrathyroidal T cell clones from patients with autoimmune thyroid disease | |
Balch et al. | Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients | |
Damle et al. | Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+ CD45R-p80+ subpopulation. | |
EP0025722B1 (en) | Monoclonal antibody to human cytotoxic and suppressor t cells, and method of preparing it | |
JACKSON et al. | Ia+ T cells in new onset Graves' disease | |
EP0017381A2 (en) | Monoclonal antibody to human T cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it | |
Eguchi et al. | Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease. | |
Lederman et al. | Defective suppressor cell generation in juvenile onset diabetes. | |
Pawelec et al. | Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative" helper" T cell clones. | |
Douglas Petersen et al. | Autoreactive and immunoregulatory T-cell subsets in insulindependent diabetes mellitus | |
Bagnasco et al. | Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid | |
REINsMoEN et al. | DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG TRANSPLANT RECIPIENTS1 | |
Pawelec et al. | Restimulation properties of human alloreactive cloned T-cell lines. Dissection of HLA-D-region alleles in population studies and in family segregation analysis | |
Gorczynski et al. | Suppression of Cytotoxic Response to Histoincompatible Cells: I. Evidence for Two Types of T Lymphocyte-Derived Suppressors Acting at Different Stages in the Induction of a Cytotoxic Response | |
Andrews et al. | The limited immunocompetence of thymocytes within murine thymic nurse cells | |
Ballas et al. | Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus. | |
Engleman et al. | Functional characteristics of human T-cell subpopulations distinguished by a monoclonal antibody | |
Stevenson et al. | Characterization of purified cryopreserved human monocyte function in assays of superoxide production, accessory cell function, chemotaxis, and in fluorescent cell sorter analysis | |
Sarawar et al. | T-cell receptor-bearing cells from athymic nude rats respond to alloantigen in vitro but are defective in vivo. | |
HAMMERSTRØM | Human adherent mononuclear blood cells: Cytolytic and cytostatic activity and characterization of effector cells during in vitro culture | |
Domingo et al. | Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures | |
Plata et al. | Characterization of Effector Lymphocytes Associated with Immunity to Murine Sarcoma Virus (MSV) Induced Tumors: I. Physical Properties of Cytolytic T Lymphocytes Generated in Vitro and of Their Immediate Progenitors | |
Romagnani et al. | Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4‐positive cells which co‐express cytolytic activity and production of interleukin‐2 | |
Canonica et al. | Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells | |
EP0939796B1 (en) | Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |